ROBERT RUSSELL: Open Payments
NPI 1407052376 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 13 payments from 5 companies in 2025. Trend: 2023 $5,710 · 2024 $5,123 · 2025 $1,025
Food & beverage: $969Travel & lodging: $56
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $387 |
| Medline Industries LP | 3 | $346 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $138 |
| ACADIA Pharmaceuticals Inc | 1 | $120 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $33 |
Products named: NUPLAZID, INGREZZA, REXULTI.
Industry payments across IN — which companies pay providers there.
